Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 29730546 | HLA-G (HLA-G) | endometrial cancer | NA | NA | NA | unclassified | |
| increased plasmatic soluble hla-g levels in endometrial cancer. | |||||||
| 29730546 | HLA-G (HLA-G) | endometrial cancer | NA | NA | NA | unclassified | |
| to the best of our knowledge this is the first study that focuses on the expression of soluble hla-g (shla-g) in endometrial cancer (ec). | |||||||
| 33159014 | HLA-DPB1 (HLA-DPB1) | endometrial cancer | NA | NA | NA | only_studied | |
| our results identified cd74, hla-drb5, cd52, hla-dpb1 and hla-drb1 as possible valuable genetic markers for the diagnosis and prognosis of endometrial cancer and provided a theoretical basis for immunotherapy targets for its clinical treatment. | |||||||
| 33159014 | HLA-DRB1 (HLA-DRB1) | endometrial cancer | NA | NA | NA | only_studied | |
| our results identified cd74, hla-drb5, cd52, hla-dpb1 and hla-drb1 as possible valuable genetic markers for the diagnosis and prognosis of endometrial cancer and provided a theoretical basis for immunotherapy targets for its clinical treatment. | |||||||
| 30416723 | HLA-DRB1 (HLA-DRB1) | entamoeba histolytica infection | Iraqi | NA | NA | unclassified | |
| association between entamoeba histolytica infection and human leukocyte antigen hla- drb1. | |||||||
| 30416723 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | entamoeba histolytica infection | Iraqi | NA | NA | unclassified | |
| association between entamoeba histolytica infection and human leukocyte antigen hla- drb1. | |||||||
| 30416723 | HLA-DRB1 (HLA-DRB1) | entamoeba histolytica infection | Iraqi | NA | NA | unclassified | |
| the innate and adaptive immunity are important in protection against infection.aim of the studyto investigate the association between hla-drb1 and entamoeba histolytica infection.patients and methodsthe study is a case-controlled consisted from thirty iraqi arab muslims patients with entamoeba histolytica infection. | |||||||
| 30416723 | HLA-DRB1 (HLA-DRB1) | entamoeba histolytica infection | Iraqi | NA | NA | unclassified | |
| hla-drb1 was done by ssop method.resultsa total of 30 patients with entamoeba histolytica infection were participated in this study. | |||||||
| 30416723 | HLA-DRB1 (HLA-DRB) | amebiasis | Iraqi | NA | NA | positive | |
| there was an increased frequency of hladrb1*03:0101 and *11:0101 in patients group compared to control group (p = 0.002, odds ratio = 7.42, 95% ci:2.07 to 26.55) and (p = 0.01, odd ratio = 4.29, 95% ci: 1.41 to 13.06) respectively.conclusionshla-drb1*03:0101 and hla-drb1*110,101 may have a role in susceptibility to amebiasis. | |||||||
| 30416723 | HLA-DRB1*03 | amebiasis | Iraqi | NA | NA | positive | |
| there was an increased frequency of hladrb1*03:0101 and *11:0101 in patients group compared to control group (p = 0.002, odds ratio = 7.42, 95% ci:2.07 to 26.55) and (p = 0.01, odd ratio = 4.29, 95% ci: 1.41 to 13.06) respectively.conclusionshla-drb1*03:0101 and hla-drb1*110,101 may have a role in susceptibility to amebiasis. | |||||||
Copyright 2024